Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (798)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,081
Price
$27.57
Total Value
$167.65K
Shares Held After
383,602
% of Holdings
1.6%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
18,698
Price
$28.61
Total Value
$534.95K
Shares Held After
220,867
% of Holdings
7.8%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
8,094
Price
$27.52
Total Value
$222.75K
Shares Held After
239,565
% of Holdings
3.3%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
413
Price
$115.54
Total Value
$47.72K
Shares Held After
9,938
% of Holdings
4.0%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
810
Price
$115.40
Total Value
$93.47K
Shares Held After
5,683
% of Holdings
12.5%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
2
Price
$170.02
Total Value
$340.04
Shares Held After
14,500
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
14
Price
$169.36
Total Value
$2.37K
Shares Held After
14,502
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
12
Price
$168.21
Total Value
$2.02K
Shares Held After
14,516
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
78
Price
$167.59
Total Value
$13.07K
Shares Held After
14,528
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
50
Price
$166.44
Total Value
$8.32K
Shares Held After
14,606
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
120
Price
$165.49
Total Value
$19.86K
Shares Held After
14,656
% of Holdings
0.8%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
24
Price
$164.64
Total Value
$3.95K
Shares Held After
14,776
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Scholl Hendrik Peter — Chief Medical Officer
Shares
200
Price
$163.62
Total Value
$32.73K
Shares Held After
14,800
% of Holdings
1.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
38,796
Price
$2.04
Total Value
$78.96K
Shares Held After
2,836,963
% of Holdings
1.4%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
11,767
Price
$2.86
Total Value
$33.66K
Shares Held After
155,983
% of Holdings
7.0%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
900
Price
$36.57
Total Value
$32.91K
Shares Held After
14,954
% of Holdings
5.7%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
16,850
Price
$36.08
Total Value
$607.95K
Shares Held After
15,854
% of Holdings
51.5%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
799
Price
$79.67
Total Value
$63.66K
Shares Held After
5,173
% of Holdings
13.4%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
2,970
Price
$78.82
Total Value
$234.10K
Shares Held After
5,972
% of Holdings
33.2%
Monopar Therapeutics (MNPR)
STARR CHRISTOPHER M — Director
Shares
4,631
Price
$78.09
Total Value
$361.63K
Shares Held After
8,942
% of Holdings
34.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
16,431
Price
$1.33
Total Value
$21.85K
Shares Held After
908,532
% of Holdings
1.8%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.42
Total Value
$14.20K
Shares Held After
1,580,294
% of Holdings
0.6%
Enliven Therapeutics, Inc. (ELVN)
Garland J. Scott — Director
Shares
13,000
Price
$46.67
Total Value
$606.72K
Shares Held After
0
% of Holdings
100.0%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$230.33
Total Value
$1.38M
Shares Held After
345,875
% of Holdings
1.7%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
2,600
Price
$93.46
Total Value
$243.00K
Shares Held After
2,845
% of Holdings
47.8%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
2,100
Price
$92.70
Total Value
$194.67K
Shares Held After
5,445
% of Holdings
27.8%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
7,228
Price
$91.35
Total Value
$660.28K
Shares Held After
7,545
% of Holdings
48.9%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
16,605
Price
$90.35
Total Value
$1.50M
Shares Held After
14,773
% of Holdings
52.9%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
400
Price
$89.24
Total Value
$35.70K
Shares Held After
31,378
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
229
Price
$93.57
Total Value
$21.43K
Shares Held After
79,762
% of Holdings
0.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
3,071
Price
$92.95
Total Value
$285.45K
Shares Held After
79,991
% of Holdings
3.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,100
Price
$91.92
Total Value
$193.03K
Shares Held After
83,062
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,500
Price
$90.27
Total Value
$135.41K
Shares Held After
85,162
% of Holdings
1.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
600
Price
$89.07
Total Value
$53.44K
Shares Held After
86,662
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
100
Price
$93.91
Total Value
$9.39K
Shares Held After
537,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
4,990
Price
$93.37
Total Value
$465.92K
Shares Held After
537,640
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,989
Price
$92.31
Total Value
$368.22K
Shares Held After
542,630
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,638
Price
$91.49
Total Value
$241.35K
Shares Held After
546,619
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,683
Price
$90.10
Total Value
$241.74K
Shares Held After
549,257
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
600
Price
$89.14
Total Value
$53.48K
Shares Held After
551,940
% of Holdings
0.1%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
378
Price
$1.19
Total Value
$449.82
Shares Held After
23,404
% of Holdings
1.6%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
200
Price
$84.78
Total Value
$16.96K
Shares Held After
923,128
% of Holdings
0.0%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
8,554
Price
$84.03
Total Value
$718.75K
Shares Held After
923,328
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
16,246
Price
$83.40
Total Value
$1.35M
Shares Held After
931,882
% of Holdings
1.7%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
187
Price
$24.41
Total Value
$4.56K
Shares Held After
50,984
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
95
Price
$57.09
Total Value
$5.42K
Shares Held After
145,435
% of Holdings
0.1%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
2,155
Price
$56.65
Total Value
$122.09K
Shares Held After
145,530
% of Holdings
1.5%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,141
Price
$26.93
Total Value
$434.74K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
31,908
Price
$27.02
Total Value
$862.19K
Shares Held After
191,447
% of Holdings
14.3%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$27.02
Total Value
$70.07K
Shares Held After
15,558
% of Holdings
14.3%
798 transactions